CLINICAL_TRIALS
trial_result
· 2017-10-04
Clinical Trial Update: Nilotinib in the Treatment of Systemic Sclerosis [Phase 2]
Summary
Phase 2 clinical trial on nilotinib for systemic sclerosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hospital for Special Surgery, New York | Conditions: Systemic Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2017-10-04